FMOD and bladder transitional cell carcinoma: The results revealed significant differences in the expression of CSPG4 (p = 0.014), HS3ST3B1 (p = 0.00017), and FMOD (p = 6e-11) among the different BLCA pathological stages (Figure 5A).